EUROPEAN JOURNAL OF

PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

 ISSN (O) : 2394-3211

 ISSN (P) : 3051-2573

Impact Factor: 8.158

ICV - 79.57

Abstract

CUTANEOUS LUPUS ERYTHEMATOSUS: A SYSTEMIC REVIEW TO ITS EPIDEMIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT

Amit Kumar, Kapil Kumar Verma and Inder Kumar*

ABSTRACT

Information on the etiology of lupus erythematosus has advanced fast in the last decade, bringing with it promising new medicines for the treatment of cutaneous lupus erythematosus (CLE). It is divided into acute, subacute, and chronic subtypes, which are often recognized based on clinical criteria as well as histopathological and laboratory results. Although sunlight has been suspected for decades to play a role in the development of cutaneous lupus erythematosus (CLE), only recent research on the effects of ultraviolet irradiation on the skin of CLE patients has resulted in a more comprehensive model for the disease's pathogenesis. Significant progress has recently been achieved in elucidating the mechanisms involved in their development, allowing for the prediction of future targets for more successful therapies. Individual variables may contribute to the heterogeneity of CLE, and we speculate that the predominant inflammatory signature defined by T cells, B cells, PDCs, a strong lesional type interferon (IFN) response, or combinations of the above may be suitable to predict therapeutic response to targeted treatment. Pretherapeutic histological evaluation of the infiltrate could thus stratify patients with refractory CLE for T-cell-directed therapies (e.g., dapirolizumab pegol), B-cell-directed therapies (e.g., belimumab), PDC-directed therapies (e.g., litiflimab), or IFN-directed therapies (e.g., anifrolumab). This review provides an overview of CLE, including its epidemiology, clinical manifestations, pathophysiology, diagnosis, and available treatments, and concludes with the importance of early intervention.

Keywords: Cutaneous lupus erythematosus (CLE), Pretherapeutic histological evaluation, T-cell-directed therapies, B-cell-directed therapies, PDC-directed therapies, IFN-directed therapies, Refractory CLE.


[Full Text Article] [Download Certificate]

EJMPR Citation Report

  All Since 2021
 Citation  4339  2797
 h-index  23  20
 i10-index  109  52

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2026 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2026 issue has been successfully launched on 1 NOVEMBER 2026.

  • EJPMR: New Impact Factor 2026

    EJPMR Impact Factor has been Increased from 7.065 to 8.158, for Year 2026

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

BEST ARTICLE AWARDS

European Journal of Pharmaceutical and Medical Research is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Prof. Dr. Dhrubo Jyoti Sen
Download Article : Click Here

Google Scholar

Indian Science Publications

InfoBase Index (In Process)

SOCOLAR, China

Research Bible, Fuchu, Tokyo. JAPAN

International Society for Research activity (ISRA)

Scientific Indexing Services (SIS)

Polish Scholarly Bibliography

Global Impact Factor (GIF) (Under Process)

Universal Impact Factor

International Scientific Indexing (ISI), UAE

Index Copernicus

CAS (A Division of American Chemical Society) USA (Under Process)

Directory of Open Access Journal (DOAJ, Sweden, in process)

UDLedge Science Citation Index

CiteFactor

Directory Of Research Journal Indexing (DRJI)

Indian citation Index (ICI)

Journal Index (JI, Under Process)

Directory of abstract indexing for Journals (DAIJ)

Open Access Journals (Under Process)

Impact Factor Services For International Journals (IFSIJ)

Cosmos Impact Factor

Jour Informatics (Under Process)

Eurasian Scientific Journal Index (ESJI)

International Innovative Journal Impact Factor (IIJIF)

Science Library Index, Dubai, United Arab Emirates

Pubmed Database [NLM ID: 101669306] (Under Process)

IP Indexing (IP Value 2.40)

Web of Science Group (Under Process)

Directory of Research Journals Indexing

Scholar Article Journal Index (SAJI)

International Scientific Indexing ( ISI )

Scope Database

Academia

Doi-Digital Online Identifier

ISSN National Centre

Zenodo Indexing

International CODEN Service, USA